Table 1.
N (%) | Age (mean ± SD) | Follow-up period (median (LQ; UQ)) | Number of comorbidities at T2DM diagnosis (mean ± SD) | Number of comorbidities 2 years after T2DM diagnosis (mean ± SD) (sample surviving 2 years) | Number of comorbidities 5 years after T2DM diagnosis (mean ± SD) (sample surviving 5 years) | Number of comorbidities 9 years after T2DM diagnosis (mean ± SD) (sample surviving 9 years) | |
---|---|---|---|---|---|---|---|
Total cohort | 102,394 (100) | 62.1 ± 13.1 | 4.9 (2.8; 7.3) | 1.4 ± 1.3 | 1.5 ± 1.4 (84,350) | 1.6 ± 1.4 (50,475) | 1.7 ± 1.4 (8977) |
Gender | |||||||
Females | 44,764 (43.7) | 63.7 ± 13.6 | 4.9 (2.7; 7.3) | 1.6 ± 1.4 | 1.7 ± 1.4 (36,669) | 1.8 ± 1.4 (21,830) | 1.9 ± 1.5 (3942) |
Males | 57,630 (56.3) | 60.7 ± 12.5 | 5 (2.8; 7.3) | 1.2 ± 1.2 | 1.4 ± 1.3 (47,681) | 1.5 ± 1.3 (28,645) | 1.6 ± 1.4 (5035) |
Age bands | |||||||
35–54 years | 31,545 (30.8) | 46.8 ± 5.2 | 5.1 (2.9; 7.4) | 0.8 ± 0.9 | 0.9 ± 1 (26,368) | 1 ± 1 (16,106) | 1.1 ± 1 (2893) |
55–74 years | 51,288 (50.1) | 64.2 ± 5.6 | 5.2 (3; 7.5) | 1.4 ± 1.2 | 1.6 ± 1.3 (42,950) | 1.7 ± 1.3 (26,618) | 1.9 ± 1.4 (4871) |
75+ years | 19,561 (19.1) | 81 ± 4.9 | 4.1 (2.1; 6.5) | 2.3 ± 1.6 | 2.5 ± 1.6 (15,032) | 2.6 ± 1.6 (7751) | 2.8 ± 1.5 (1213) |
IMD quintiles | |||||||
Quintile 1—least deprived | 19,110 (18.7) | 63.9 ± 12.8 | 5 (2.8; 7.3) | 1.3 ± 1.3 | 1.5 ± 1.3 (15,756) | 1.6 ± 1.4 (9574) | 1.7 ± 1.4 (1682) |
Quintile 2 | 20,722 (20.2) | 63.4 ± 13 | 5.1 (2.8; 7.4) | 1.4 ± 1.3 | 1.5 ± 1.3 (17,223) | 1.6 ± 1.4 (10,500) | 1.7 ± 1.4 (1878) |
Quintile 3 | 21,572 (21.1) | 62.7 ± 13 | 4.9 (2.8; 7.3) | 1.4 ± 1.3 | 1.5 ± 1.3 (17,811) | 1.6 ± 1.4 (10,605) | 1.8 ± 1.4 (1884) |
Quintile 4 | 21,393 (20.9) | 61 ± 13.2 | 4.9 (2.7; 7.2) | 1.4 ± 1.3 | 1.5 ± 1.4 (17,489) | 1.7 ± 1.4 (10,334) | 1.7 ± 1.4 (1839) |
Quintile 5—most deprived | 19,597 (19.1) | 59.3 ± 13 | 4.8 (2.7; 7.3) | 1.4 ± 1.4 | 1.6 ± 1.4 (16,071) | 1.7 ± 1.4 (9462) | 1.7 ± 1.4 (1694) |